ZYMEWORKS INC. Business Combination, Contingent Consideration, Liability, Noncurrent
ZYMEWORKS INC. (ZYME) had Business Combination, Contingent Consideration, Liability, Noncurrent of $0 as of 2024-12-31, per its 10-K filed 2025-03-05.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:BusinessCombinationContingentConsiderationLiabilityNoncurrent · last filed 2025-03-05
- 2024-12-31: Business Combination, Contingent Consideration, Liability, Noncurrent $0.00.
- 2024-09-30: Business Combination, Contingent Consideration, Liability, Noncurrent $0.00.
- 2024-06-30: Business Combination, Contingent Consideration, Liability, Noncurrent $0.00.
- 2024-03-31: Business Combination, Contingent Consideration, Liability, Noncurrent $308.00K.
| Period end | Business Combination, Contingent Consideration, Liability, Noncurrent |
|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-03-05 |
| 2024-09-30 | $0.00 10-Q · filed 2024-10-31 |
| 2024-06-30 | $0.00 10-Q · filed 2024-08-01 |
| 2024-03-31 | $308.00K 10-Q · filed 2024-05-02 |
| 2023-12-31 | $308.00K 10-K · filed 2025-03-05 |
| 2023-09-30 | $308.00K 10-Q · filed 2023-11-07 |
| 2023-06-30 | $1.75M 10-Q · filed 2023-08-10 |
| 2023-03-31 | $1.75M 10-Q · filed 2023-05-08 |
| 2022-12-31 | $1.25M 10-K · filed 2024-03-06 |
| 2022-09-30 | $1.25M 10-Q · filed 2022-11-08 |
| 2021-12-31 | $1.50M 10-K · filed 2023-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |